Pu
•biom
e
Human•Topics
Carbohydrate digestion
Overview
Amylose & amylopectin
Undigestible carbs
Foods with fibre
Protein digestion
Fat digestion
Human Milk Oligosaccharides
Overview
HMO Structural Guide
Di- & Trisaccharides
Tetraose & Tetrasaccharides
Pentaose
Hexaose
Octaose
Decaose
Miscellaneous
MUC2 Oligosaccharides
Antibiotics vs Good Bacteria
Human / Bacteria Digestion
Carbohydrates
Monosaccharides
Polyols
Di- & tri-saccharides
Polysaccharides
Miscellaneous
Organic acids
SMCF Acids
Polyacids
Hydroxy-, Oxo-acids and Miscell.
Aromatic Acids
Amino acids
21 Original
Unconventional
Other
Nitrogen cmpds
Bacteria•Topics
Guide to Tables
General Physiology
Bacteria & Health
Substrate Utilisation
Carbohydrates
Monosaccharides and polyols
Oligo- & polysaccharides
Miscellaneous
Organic acids
SMCF Acids
Polyacids
Miscellaneous
Amino acids
21 Original
Unconventional
Other
Nitrogen cmpds
Antibiotic activity against
Penicillins and Penems
Cephems
Aminoglycosides and Macrolides
Quinolones and Tetracyclines
Glycopeptides and Polyketides
Heterocycles and Miscellaneous
All Antibiotics
Oxidation / Fermentation
Monosaccharides & polyols
Oligo- & Poly-saccharides
Miscellaneous
Biochemical Tests
Metabolites Produced
Bacterial Enzymes
General enzymes
'Carbo'sidases
Esterases
Proteases
Amidases
Hydrolysis / Digestion
Resources
Reference List
Ref List (Alt.)
Create Ref
Search
Login
Submit
Update:
Abbrescia2015
Title
*
Keywords
Bacteria
Citation
*
Authors
DOI/PMIB
Journal
Year
Volume
Issue
Pages
Notes
<div class="well-"> <h4><strong>Abstract: </strong></h4> <p>Recently has been acknowledged the healthy use of Bacillus and related bacteria as probiotics. A mixture reported to contain four probiotic strains of Bacillus clausii is marketed as an OTC (Over The Counter) medicinal supplement for human use. Their poliantibiotic resistant property, useful for restoring the gut microbiota during antibiotic treatment, raises the question about the risk of resistance transfer. In order to better assess the risk-benefit ratio it is important to always monitoring the pattern and stability of resistance spectra in these bacteria. In this work, we have extensively redefined the antibiotic susceptibility profile of these four probiotic strains. Resistance phenotype has been determined by screening a large number of antibiotics, including natural products (such as penicillin, vancomycin and erythromycin), and completely synthetic molecules (such as fluoroquinolones). Extensive comparison with a wild type strain belonging to the normal intestinal microbiome was carried out. The molecular basis of some resistances was determined. Observed antibiotic resistances were correlated with previous and new data in safety evaluations of these strains for human use.</p> </div>
Submit